본문 바로가기 주메뉴 바로가기 하단메뉴 바로가기

GC녹십자MS

  • Contact / Q&A
  • recruitment
  • KOREA
  • SITEMAP
  • Company Introduction
  • Product Information
  • R&D
  • CSR
  • INVESTORS
 

INVESTORS

Green Cross Medical Science will perform clean and transparent management.

IPO/Dividend

print

Dividend

Dividend yield for the recent three fiscal years
Dividend yield for the recent three fiscal years
Category   Term 17 Term 16 Term 15
Par value (won)   500 500 500
Net income (million won)   (16,350) (11,229) (1,672)
Net income per share (won)   (1,468) (1,126) (142)
Total cash dividends (million won)   - - -
Total stock dividends (million won)   - - -
Sash dividend payout ratio   - - -
Cash dividend yield ratio (%) Common stock - - -
Preferred stock - - -
Stock dividend yield ratio (%) Common stock - - -
Preferred stock - - -
Cash dividends per share (won) Common stock - - -
Preferred stock - - -
Stock dividends per share (%) Common stock - - -
Preferred stock - - -

[As of March 24, 2020]